439 related articles for article (PubMed ID: 29719505)
1. Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Zeng XS; Geng WS; Jia JJ; Chen L; Zhang PP
Front Aging Neurosci; 2018; 10():109. PubMed ID: 29719505
[TBL] [Abstract][Full Text] [Related]
2. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
3. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
4. PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease.
Mouton-Liger F; Jacoupy M; Corvol JC; Corti O
Front Mol Neurosci; 2017; 10():120. PubMed ID: 28507507
[TBL] [Abstract][Full Text] [Related]
5. VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease.
Tang FL; Erion JR; Tian Y; Liu W; Yin DM; Ye J; Tang B; Mei L; Xiong WC
J Neurosci; 2015 Jul; 35(29):10613-28. PubMed ID: 26203154
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of Parkinson disease.
Eriksen JL; Wszolek Z; Petrucelli L
Arch Neurol; 2005 Mar; 62(3):353-7. PubMed ID: 15767499
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in Parkinson's disease.
Hu Q; Wang G
Transl Neurodegener; 2016; 5():14. PubMed ID: 27453777
[TBL] [Abstract][Full Text] [Related]
8. Parkinson disease: from pathology to molecular disease mechanisms.
Dexter DT; Jenner P
Free Radic Biol Med; 2013 Sep; 62():132-144. PubMed ID: 23380027
[TBL] [Abstract][Full Text] [Related]
9. [Molecular basis of Parkinson's disease linked with mutations in the LRRK2 gene].
Pchelina SN; emel'ianov AK; Usenko TS
Mol Biol (Mosk); 2014; 48(1):3-14. PubMed ID: 25842821
[TBL] [Abstract][Full Text] [Related]
10. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
11. [Frontier researches for the development of molecular-targeted therapies for familial Parkinson disease].
Imai Y; Takahashi R
Brain Nerve; 2009 Aug; 61(8):903-13. PubMed ID: 19697879
[TBL] [Abstract][Full Text] [Related]
12. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher JP
Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
[TBL] [Abstract][Full Text] [Related]
13. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.
Ratan Y; Rajput A; Pareek A; Pareek A; Jain V; Sonia S; Farooqui Z; Kaur R; Singh G
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254673
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.
Calì T; Ottolini D; Brini M
Biofactors; 2011; 37(3):228-40. PubMed ID: 21674642
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.
Soria FN; Engeln M; Martinez-Vicente M; Glangetas C; López-González MJ; Dovero S; Dehay B; Normand E; Vila M; Favereaux A; Georges F; Lo Bianco C; Bezard E; Fernagut PO
Hum Mol Genet; 2017 Jul; 26(14):2603-2615. PubMed ID: 28520872
[TBL] [Abstract][Full Text] [Related]
16. Animal models for Parkinson's disease.
Patil DA; Patil VA; Bari SB; Surana SJ; Patil PO
CNS Neurol Disord Drug Targets; 2014; 13(9):1580-94. PubMed ID: 25106631
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and Parkinson's disease.
Blesa J; Trigo-Damas I; Quiroga-Varela A; Jackson-Lewis VR
Front Neuroanat; 2015; 9():91. PubMed ID: 26217195
[TBL] [Abstract][Full Text] [Related]
18. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
19. The paths to neurodegeneration in genetic Parkinson's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2014; 13(9):1485-512. PubMed ID: 25106632
[TBL] [Abstract][Full Text] [Related]
20. [Function study advances of Parkinson disease related genes].
Wang XM; Wang DQ; Wang XY
Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
